Highlights•Lipid nanoparticles are the leading non-viral platform for safe and effective
delivery of RNA-based vaccines and therapeutics.•Upon administration, RNA-lipid …

The membrane‐protein interface on lipid‐based nanoparticles influences their in vivo
behavior. Better understanding may evolve current drug delivery methods toward effective …

The composition and morphology of lipid-based nanoparticles can influence their overall in
vivo behavior. Previously, we demonstrated that phase separation in liposomes composed …

Improving target versus off‐target ratio in nanomedicine remains a major challenge for
increasing drug bioavailability and reducing toxicity. Active targeting using ligands on …

The membrane-protein interface in lipid nanoparticles (LNPs) is important for their in vivo
behavior. Better understanding may assist to evolve current drug delivery methods to more …

Improving target versus off-target ratio in nanomedicine remains a major challenge for
increasing drug bioavailability and reducing toxicity. Active targeting using ligands on …

Lipid nanoparticle (LNP) technology has unlocked the potential of mRNA therapeutics, and
current developments in the field focus on tissuetargeted therapies for disease-specific …

Ad ancing image-based localization of lipid-based nanomedicines for the exploration of targeted
drug deli er Page 1 Ad ancing image-based localization of lipid-based nanomedicines for the …